Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Balchem Corporation

Market Cap 5.33B 4.65B 4.3B 4.03B 7.56B 503B 7.6B 51.07B 19.79B 248B 20.01B 19.58B 860B P/E 2026 *
31.7x
P/E 2027 * 30.1x
Enterprise Value 5.36B 4.68B 4.33B 4.05B 7.6B 506B 7.65B 51.38B 19.91B 249B 20.13B 19.7B 865B EV / Sales 2026 *
4.85x
EV / Sales 2027 * 4.54x
Free-Float
99.53%
Yield 2026 *
0.68%
Yield 2027 * 0.76%
1 day+0.94%
1 week+0.53%
Current month+5.86%
1 month+2.58%
3 months+2.41%
6 months+6.15%
Current year+8.19%
1 week 162.09
Extreme 162.09
166.53
1 month 152.91
Extreme 152.91
167.98
Current year 152.58
Extreme 152.58
183.9
1 year 139.17
Extreme 139.17
183.9
3 years 110.74
Extreme 110.74
186.03
5 years 110.15
Extreme 110.1456
186.03
10 years 57.05
Extreme 57.05
186.03
Manager TitleAgeSince
Chief Executive Officer 61 2015-04-27
Director of Finance/CFO 49 2019-02-03
Chief Tech/Sci/R&D Officer 56 2025-09-30
Director TitleAgeSince
Director/Board Member 63 2010-09-15
Chairman 61 2016-12-31
Director/Board Member 59 2015-09-14
Date Insider Type Main position Quantity % Market Cap.
03-31Other

Controller/Auditor

8,646 0.0270%
02-10Free

Director

870 0.0027%
02-10Free

Director

870 0.0027%
Change 5-day change 1-year change 3-year change Capi.($)
+0.94%+0.53%+6.35%+24.15% 5.33B
+0.02%+1.40%+3.02%+48.87% 75.74B
+1.85%+2.20%-18.70%+12.80% 37.17B
-1.12%+5.48%-22.62%-31.04% 32.51B
+0.12%-1.57%+10.48%+17.62% 25.08B
-3.98%-5.27%+148.41%+9.80% 22.76B
+1.43%+1.72%+20.73%+6.92% 20.58B
-3.73%-5.91%+183.00%-30.40% 18.91B
+0.51%+3.02% - - 13.59B
+0.12%+4.18%-10.87%-7.24% 13.53B
Average -0.39%+2.08%+35.53%+5.72% 26.52B
Weighted average by Cap. -0.31%+2.13%+24.69%+13.64%

Financials

2026 *2027 *
Net sales 1.11B 965M 893M 836M 1.57B 104B 1.58B 10.6B 4.11B 51.39B 4.15B 4.06B 178B 1.16B 1.02B 941M 881M 1.65B 110B 1.66B 11.16B 4.33B 54.11B 4.37B 4.28B 188B
Net income 170M 148M 137M 128M 240M 16.01B 242M 1.63B 630M 7.88B 637M 623M 27.36B 179M 156M 144M 135M 253M 16.85B 255M 1.71B 663M 8.29B 670M 656M 28.8B
Net Debt 31.98M 27.88M 25.82M 24.17M 45.33M 3.02B 45.61M 306M 119M 1.49B 120M 117M 5.16B -40.26M -35.1M -32.51M -30.44M -57.08M -3.8B -57.43M -386M -149M -1.87B -151M -148M -6.49B
Logo Balchem Corporation
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Employees
1,368
Date Price Change Volume
26-06-18 165.92 $ +0.94% 511,280
26-06-17 164.38 $ +0.13% 274,955
26-06-16 164.17 $ +0.30% 267,992
26-06-15 163.68 $ -0.82% 208,804
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
165.92USD
Average target price
200.75USD
Spread / Average Target
+20.99%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BCPC Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!